As part of our Advocacy work, the CSPA often prepares submissions on consultations run by governments across Canada on important topics that affect skin patients.
CSPA supported a joint submission to the federal government's rare disease drug strategy consultation in March 2021 asking the federal government to include cancers - and rare cancers, in particular - in the strategy.
The CSPA signed on to a joint letter from cancer patient organizations earlier this year regarding increases to the Canada Health Transfer. A copy of the letter was sent to the minister of health, deputy minister, and Chief Medical Officer or Chief Public Health Officer of each province
CSPA Federal 2021 Pre-budget Submission - February 2021 (pdf)
PMPRB Guidelines Submission - August 2020 (pdf)
CSPA Federal 2021 pre-budget submission - August 2020 (pdf)
Ontario Pre-Budget Submission - March 2020 (pdf)
PMPRB Submission Guidelines Consultation (Drug Pricing) - Feb 2020 (pdf)
